March 30, 2026
PHC Corporation
Please be advised that the following changes will take place at PHC Corporation (headquarters: Chiyoda-ku, Tokyo) effective April 1, 2026. The official decision has been made at the Board of Directors Meeting held on March 10 and the Extraordinary General Meeting of Shareholders on March 12.
1. Changes in Board Member on April 1, 2026
New Appointment
| Position/Title |
Name |
Remarks |
| Director (part-time) |
Peter Bodlund |
Corporate Officer, Head of Diabetes Management Business,
PHC Holdings Corporation
President, Ascensia Diabetes Care Holdings AG |
2. Board Members at PHC Corporation on April 1, 2026
| Position/Title |
Name |
Remarks |
President,
Representative Director |
Nobuaki Nakamura |
Executive Corporate Officer,
Head of Diagnostics & Life Sciences Domain,
PHC Holdings Corporation |
| Representative Director & Senior Executive Director |
Chikara Takauo |
Corporate Officer,
Head of Life Sciences Business, R&D,
PHC Holdings Corporation |
| Director |
Hiroyuki Tokunaga |
POCT and Injector Strategy,
PHC Corporate-wide Projects |
| Director (part-time) |
Masashi Kimura |
Executive General Manager of Corporate Administration Department,
PHC Holdings Corporation |
| Director (part-time) |
Mayumi Matsumoto |
Executive General Manager of Corporate Treasury and Group Tax,
PHC Holdings Corporation |
| Director (part-time) |
Peter Bodlund |
Corporate Officer,
Head of Diabetes Management Business, PHC Holdings Corporation
President, Ascensia Diabetes Care Holdings AG |
Audit and Supervisory
Board Member (part-time) |
Ryo Kamakura |
General Manager of Human Resources Department,
PHC Holdings Corporation |
Media contact
Investor Relations & Corporate Communications Department
PHC Holdings Corporation
+81-3-6778-5311
Email: phc-pr@gg.phchd.com